Related Experiment Video

Updated: Mar 13, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K

Contribution of SWEET to improve paediatric diabetes care in developing countries

Danièle Pacaud1, Jean-François Lemay2, Erick Richmond3

  • 1Alberta Children's Hospital, Department of Paediatrics, University of Calgary, Calgary, Canada. daniele.pacaud@ahs.ca.

Pediatric Diabetes
|October 18, 2016
PubMed

Insights

Caring for children with diabetes in developing nations presents unique challenges. The SWEET initiative highlights how resource-limited centers strive for optimal pediatric diabetes care despite obstacles.

Area of Science:

  • Pediatric Endocrinology
  • Global Health
  • Diabetes Management

Background:

  • Diabetes Mellitus significantly impacts children in developing countries.
  • Limited resources pose substantial challenges to pediatric diabetes care.
  • The SWEET initiative aims to improve diabetes management in underserved regions.

Purpose of the Study:

  • To share perspectives from SWEET centers in developing countries on pediatric diabetes care.
  • To describe the populations served, care organization, and daily challenges.
  • To outline anticipated benefits and challenges of participating in the SWEET initiative.

Main Methods:

  • Informal survey of five SWEET centers in developing countries (Mali, Costa Rica, Argentina, India).
  • Centers provided descriptions of patient demographics, care structures, and encountered difficulties.
  • Analysis of reported benefits and challenges associated with SWEET participation.

Main Results:

  • Detailed insights into the realities of pediatric diabetes care in resource-limited settings.
  • Identification of specific challenges faced by healthcare teams in Mali, Costa Rica, Argentina, and India.
  • Exploration of the practical advantages and hurdles of engaging with the SWEET program.

Conclusions:

  • Dynamic teams in resource-limited environments are dedicated to achieving recommended pediatric diabetes care standards.
  • The SWEET initiative serves as a crucial platform for sharing experiences and improving care globally.
  • Understanding these realities is vital for developing targeted support for pediatric diabetes management in developing nations.

Keywords:
developing countriesdiabetes careorganization of carepediatric diabetestype 1 diabetes

More Related Videos

Psychophysical Tracking Method to Measure Taste Preferences in Children and Adults09:17

Psychophysical Tracking Method to Measure Taste Preferences in Children and Adults

Published on: July 16, 2016

18.3K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.4K

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.8K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.1K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.0K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
28.0K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K